Holistic Weight Loss Service in Maryland
Why I Call GLP-1 Therapies the Medication of the Century
GLP-1 therapies have redefined modern medicine by tackling insulin resistance, obesity, and chronic inflammation. They improve blood sugar, support weight loss, protect the heart, kidneys, and liver, and even show promise in brain health. This article highlights why these versatile medications truly deserve recognition as the medication of the century.
Published
Categorized as Diabetes Care, Insights from Dr. Tashko, Insulin Resistance, Metabolic Longevity, Obesity Care
SUMMIT Trial: Tirzepatide Reduces Heart Failure Risk in Patients with Obesity
The SUMMIT trial investigated how tirzepatide (Mounjaro or Zepbound), a weight-loss medication, affects heart failure with preserved ejection fraction (HFpEF) in patients with obesity. HFpEF, where the heart pumps effectively but struggles to fill properly, is more common in individuals with high body mass index (BMI). Researchers aimed to determine whether tirzepatide could improve cardiovascular outcomes and enhance quality of life for this population.
Published
Can GLP-1s, Semaglutide and Liraglutide Treat Alcohol Use Disorder?
Alcohol Use Disorder (AUD) remains a major global health issue. While psychosocial treatments dominate, medications play a lesser role. Exciting new findings suggest GLP-1 agonists, primarily used for type 2 diabetes and obesity, may help. Among these, semaglutide and liraglutide show the strongest potential for reducing alcohol-related hospitalizations. Though promising, further research is necessary to confirm these results.
Published
Retatrutide: A Promising Breakthrough for Fatty Liver Disease
Fatty liver disease has become a global health crisis, affecting millions worldwide. Now called metabolic dysfunction-associated steatotic liver disease (MASLD), its prevalence has skyrocketed due to rising obesity rates. Retatrutide, a triple hormone receptor agonist, is showing a game-changing potential in reducing liver fat and improving metabolic health.
Published